Epoetin alfa

Epoetin alfa (rINN) (pronounced /ɛˈpoʊɨtɨn/) is a synthetic form of erythropoietin. It stimulates erythropoiesis (increases red blood cell levels) and is used to treat anemia, commonly associated with chronic renal failure and cancer chemotherapy. Epoetin is marketed under the trade names Procrit and Epogen. Epoetin alfa is well-tolerated. Common side effects include high blood pressure, headache, joint-pain and clotting at the injection site. Ra... more

Also known as:

  • EPOGEN

Medicine

Used To Treat:

top ↑

Facts from the Community

From the BioVenturist base

Sales:

Amount Year Area
  • 2,511,000,000
  • 2006
  • 2,455,000,000
  • 2005
  • 2,489,000,000
  • 2007
View entire collection »

Stage of development:

Indication or disease:

Disease Phase of development
top ↑

We can also tell you Epoetin alfa is a…

If you know more about Epoetin alfa, you can add more facts here »

These people have edited this topic:

Edit this topic
Edit and Show details

Add or delete facts, download data in JSON or RDF formats, and explore topic metadata.

Freebase Logo
What is Freebase?

Freebase is a huge collection of facts, built by people like you. Freebase connects facts in ways other sites can't, giving you new ways to explore millions of subjects.
You can help improve it!

Freebase Attribution

Freebase data is free for use under the CC-BY license.

The original description for Epoetin alfa was automatically generated from Wikipedia.org licensed under the GNU Free Documentation License.
[1]
Learn more about Freebase licensing and attribution